[PLX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
15-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -90.38%
YoY- 54.24%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 9,588 8,617 14,183 8,753 16,085 8,549 12,054 -14.16%
PBT -2,936 -3,210 -3,567 -5,334 -2,286 -6,667 -4,199 -21.23%
Tax 195 530 442 -190 416 908 96 60.45%
NP -3,131 -3,740 -4,009 -5,144 -2,702 -6,667 -4,199 -17.78%
Tax Rate - - - - - - - -
Total Cost 12,719 12,357 18,192 13,897 18,787 15,216 16,253 -15.09%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -32.66 -43.40 -28.27 -58.77 -16.80 -77.99 -34.83 -4.20%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.05 -0.07 -0.08 -0.11 -0.06 -0.15 -0.09 -32.44%
EPS Diluted -0.05 -0.07 -0.08 -0.11 -0.06 -0.15 -0.09 -32.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.